āĻšā§āĻŽLSI âĸ FRA
add
CK Life Sciences Intl (Holdings) Inc
ā§Ļ.ā§Ļā§¯ā§¨âŦ
ā§§ā§Ŧ āĻāĻžāĻ¨ā§, ā§§ā§Ļ:ā§Ģā§¯:ā§Ēā§Ē PM GMT +ā§§ · EUR · FRA · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§Ļ.ā§Ļā§¯ā§¨âŦ
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§Ļ.ā§Ļā§¯ā§¨âŦ - ā§Ļ.ā§Ļā§¯ā§¨âŦ
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§Ļ.ā§Ļā§Ēā§âŦ - ā§Ļ.ā§§ā§§âŦ
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§Žā§¨ā§Ŧ.ā§Ŧā§Â āĻā§ HKD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§Ŧā§ā§¯.ā§Ļā§Ļ
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
-
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
HKG
āĻŦāĻžāĻāĻžāĻ° āĻ¸āĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (HKD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§§ā§Šā§Ļ.ā§¨ā§¯Â āĻā§ | -ā§§.ā§§ā§Ē% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§Ēā§§.ā§Šā§Ŧ āĻā§ | ā§¨ā§.ā§Žā§Ŧ% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§.ā§Ģā§Ē āĻā§ | -ā§§ā§Ģ,ā§§ā§Ŧā§Ž.ā§Ŧā§Š% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | -ā§Ģ.ā§ā§¯ | -ā§§ā§Ē,ā§Ģā§ā§Ģ.ā§Ļā§Ļ% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | â | â |
EBITDA | ā§Ēā§Ŧ.ā§Ģā§Ģ āĻ˛āĻž | -ā§¯ā§Ģ.ā§Šā§§% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | -ā§§ā§§.ā§Žā§Ģ% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (HKD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§ā§¯.ā§ā§ŽÂ āĻā§ | ā§Ēā§§.ā§¯ā§Ē% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§§.ā§§ā§ŠāĻļāĻ¤Â āĻā§ | ā§Š.ā§Ŧā§Ŧ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§ā§Ŧā§Š.ā§Šā§Ē āĻā§ | ā§§ā§§.ā§Ļā§Ē% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Šā§Ŧā§Ģ.ā§Šā§§Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§¯ā§Ŧā§§.ā§§ā§§Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§Ļ.ā§¨ā§Ē | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Ļ.ā§Šā§% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | -ā§Ļ.ā§Ēā§§% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (HKD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§.ā§Ģā§Ē āĻā§ | -ā§§ā§Ģ,ā§§ā§Ŧā§Ž.ā§Ŧā§Š% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | -ā§Šā§Ļ.ā§Šā§Ļ āĻ˛āĻž | -ā§§ā§Ļā§Ē.ā§§ā§% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§¯ā§¨.ā§Ļā§¨Â āĻ˛āĻž | ā§§ā§§ā§¯.ā§¨ā§¨% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§§ā§Ļ.ā§Šā§Ģ āĻā§ | ā§¨ā§Šā§Š.ā§¨ā§¨% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§§ā§§.ā§Žā§Ŧ āĻā§ | ā§Šā§Ļā§Ģ.ā§¯ā§¯% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | -ā§Š.ā§Šā§ŽÂ āĻā§ | -ā§¨ā§¯ā§Ļ.ā§¨ā§Š% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§¨ā§Ļā§Ļā§Ļ
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§§,ā§¯ā§Šā§Ģ
